Chromatography has long been a bioprocess cornerstone but many platforms today are struggling to keep up with scale, speed, ...

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...

Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...

This approach for transporting therapeutics into cells could open up new possibilities for treating neurological disorders ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...